| תיאור כללי: |
Bayer HealthCare allocates grants for the exploration of attractive, novel drug targets in the fields of:
*Oncology: focus on anti-proliferative, survival signaling, transcription and chromatin modulation, cell cycle regulation, tumor metabolism, hypoxia, immunotherapy and antibody-drug conjugates;
*Gynecology: focus on novel treatment for endometriosis (incl. adenomyosis uteri/endometriosis interna) and uterine fibroids (uterine leiomyoma);
*Cardiology: focus on novel approaches to the care of chronic and/or acute pulmonary hypertension, atrial fibrillation, heart failure, acute coronary syndrome, ischemic stroke, peripheral arterial occlusive disease, acute lung injury/adult respiratory distress syndrome, cardiorenal syndrome and chronic kidney diseases;
*Hematology: Focus on novel, targets for hemophilia, hemoglobinopathies, bone marrow cell mobilization and renewal.
*Ophthalmology: Treatment options for dry AMD/Geographic Atrophy and Stargardt’s disease
Support Grants (€5,000-€10,000) to further advance research on targets that are at a very early stage of discovery; IP rights remain with the applicant.
Focus Grants (€10,000-€125,000) for more mature ideas, e.g. to address specific aspects of a target as a first step towards transferring it to the drug discovery process; IP rights remain with the applicant.
In addition to the financial grants, Bayer may support further by providing expertise, tools and/or investigations in the areas of: antibodies, small molecule tool compounds, biobank samples, and technologies.
http://www.grants4targets.com/scripts/pages/en/index.php
|
